These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33400275)

  • 21. Investigation of protein-ligand binding motions through protein conformational morphing and clustering of cytochrome bc1-aa3 super complex.
    Sindhu T; Rajamanikandan S; Jeyakanthan J; Pal D
    J Mol Graph Model; 2023 Jan; 118():108347. PubMed ID: 36208591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on ATP synthase inhibitors: A unique target for drug development in M. tuberculosis.
    Kelam LM; Wani MA; Dhaked DK
    Prog Biophys Mol Biol; 2023; 180-181():87-104. PubMed ID: 37105260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyrazolo[1,5- a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis.
    Lu X; Williams Z; Hards K; Tang J; Cheung CY; Aung HL; Wang B; Liu Z; Hu X; Lenaerts A; Woolhiser L; Hastings C; Zhang X; Wang Z; Rhee K; Ding K; Zhang T; Cook GM
    ACS Infect Dis; 2019 Feb; 5(2):239-249. PubMed ID: 30485737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An amiloride derivative is active against the F
    Hards K; Cheung CY; Waller N; Adolph C; Keighley L; Tee ZS; Harold LK; Menorca A; Bujaroski RS; Buckley BJ; Tyndall JDA; McNeil MB; Rhee KY; Opel-Reading HK; Krause K; Preiss L; Langer JD; Meier T; Hasenoehrl EJ; Berney M; Kelso MJ; Cook GM
    Commun Biol; 2022 Feb; 5(1):166. PubMed ID: 35210534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB.
    Moraski GC; Seeger N; Miller PA; Oliver AG; Boshoff HI; Cho S; Mulugeta S; Anderson JR; Franzblau SG; Miller MJ
    ACS Infect Dis; 2016 Jun; 2(6):393-8. PubMed ID: 27627627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the Potential Inhibition of Candidate Drug Molecules for Clinical Investigation Based on their Docking or Crystallographic Analyses against
    Dey R; Nandi S; Samadder A; Saxena A; Saxena AK
    Curr Top Med Chem; 2020; 20(29):2662-2680. PubMed ID: 32885754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting DNA Gyrase to Combat Mycobacterium tuberculosis: An Update.
    Das S; Garg T; Srinivas N; Dasgupta A; Chopra S
    Curr Top Med Chem; 2019; 19(8):579-593. PubMed ID: 30834837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triazolopyrimidines Target Aerobic Respiration in Mycobacterium tuberculosis.
    Shelton C; McNeil M; Allen R; Flint L; Russell D; Berube B; Korkegian A; Ovechkina Y; Parish T
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0204121. PubMed ID: 35262374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combinations of Respiratory Chain Inhibitors Have Enhanced Bactericidal Activity against Mycobacterium tuberculosis.
    Berube BJ; Parish T
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome
    Jeffreys LN; Ardrey A; Hafiz TA; Dyer LA; Warman AJ; Mosallam N; Nixon GL; Fisher NE; Hong WD; Leung SC; Aljayyoussi G; Bibby J; Almeida DV; Converse PJ; Fotouhi N; Berry NG; Nuermberger EL; Upton AM; O'Neill PM; Ward SA; Biagini GA
    ACS Infect Dis; 2023 Feb; 9(2):221-238. PubMed ID: 36606559
    [No Abstract]   [Full Text] [Related]  

  • 31. Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery.
    Sellamuthu S; Singh M; Kumar A; Singh SK
    Expert Opin Ther Targets; 2017 Jun; 21(6):559-570. PubMed ID: 28472892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting mycobacterial membranes and membrane proteins: Progress and limitations.
    Kumar G; Kapoor S
    Bioorg Med Chem; 2023 Mar; 81():117212. PubMed ID: 36804747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and Characterization of a Hybrid Respiratory Supercomplex Consisting of Mycobacterium tuberculosis Cytochrome bcc and Mycobacterium smegmatis Cytochrome aa3.
    Kim MS; Jang J; Ab Rahman NB; Pethe K; Berry EA; Huang LS
    J Biol Chem; 2015 Jun; 290(23):14350-60. PubMed ID: 25861988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relevance of persisters in tuberculosis drug discovery.
    Mandal S; Njikan S; Kumar A; Early JV; Parish T
    Microbiology (Reading); 2019 May; 165(5):492-499. PubMed ID: 30775961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches.
    Singh V
    Front Cell Infect Microbiol; 2021; 11():755459. PubMed ID: 34568101
    [No Abstract]   [Full Text] [Related]  

  • 37. Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels.
    O'Malley T; Alling T; Early JV; Wescott HA; Kumar A; Moraski GC; Miller MJ; Masquelin T; Hipskind PA; Parish T
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB.
    Abrahams KA; Cox JA; Spivey VL; Loman NJ; Pallen MJ; Constantinidou C; Fernández R; Alemparte C; Remuiñán MJ; Barros D; Ballell L; Besra GS
    PLoS One; 2012; 7(12):e52951. PubMed ID: 23300833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria.
    Lee BS; Kalia NP; Jin XEF; Hasenoehrl EJ; Berney M; Pethe K
    J Biol Chem; 2019 Feb; 294(6):1936-1943. PubMed ID: 30530783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacterial tuberculosis Enzyme Targets and their Inhibitors.
    Saxena AK; Singh A
    Curr Top Med Chem; 2019; 19(5):337-355. PubMed ID: 30806318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.